| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | SVP, Commercial Operations | Common Stock | 0 | $0 | $55.00 | 10 Mar 2026 | Direct |
| SUPERNUS PHARMACEUTICALS, INC. | SVP, Commercial Operations | Performance Share Unit | 0 | 06 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 06 Mar 2026 | 11 | -$483,797 | 4 | SVP, Commercial Operations | 10 Mar 2026, 16:12 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 01 Mar 2026 | 0 | $0 | 3 | SVP, Commercial Operations | 10 Mar 2026, 16:11 |